T-bet-dependent expression of osteopontin contributes to T cell polarization

被引:127
作者
Shinohara, ML
Jansson, M
Hwang, ES
Werneck, MBF
Glimcher, LH
Cantor, H
机构
[1] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
genetic programming; T helper 1 development; type-1 immune response;
D O I
10.1073/pnas.0508666102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The osteopontin (Opn) glycoprotein has been implicated in diverse physiological processes, including vascularization, bone formation, and inflammatory responses. Studies of its role in immune responses has suggested that Opn can set the early stage of type-1 immune (cell-mediated) responses through differential regulation of IL-12 and IL-10 cytokine gene expression in macrophages. Although Opn has been suggested to play a role in the development of type-1 immunity, little is known about control of Opn gene expression. Here, we report that Opn gene expression in activated T cells, but not macrophages, is regulated by T-bet, a transcription factor that controls CD4(+) T helper (Th1) cell lineage commitment. We also find that T-bet-dependent expression of Opn in T cells is essential for efficient skewing of CD4(+) T and CD8(+) T cells toward the Th1 and type 1 CD8(+) T cells (Tc1) pathway, respectively. Taken together, these findings begin to delineate the genetic basis of Opn expression in T cells and further clarify the role of Opn in Th and Tc1 development.
引用
收藏
页码:17101 / 17106
页数:6
相关论文
共 29 条
[1]   T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells [J].
Afkarian, M ;
Sedy, JR ;
Yang, J ;
Jacobson, NG ;
Cereb, N ;
Yang, SY ;
Murphy, TL ;
Murphy, KM .
NATURE IMMUNOLOGY, 2002, 3 (06) :549-557
[2]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[3]  
Blom T, 2003, SCIENCE, V299
[4]   Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice [J].
Bruemmer, D ;
Collins, AR ;
Noh, G ;
Wang, W ;
Territo, M ;
Arias-Magallona, S ;
Fishbein, MC ;
Blaschke, F ;
Kintscher, U ;
Graf, K ;
Law, RE ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) :1318-1331
[5]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[6]   Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-γ promoter [J].
Cho, JY ;
Grigura, V ;
Murphy, TL ;
Murphy, K .
INTERNATIONAL IMMUNOLOGY, 2003, 15 (10) :1149-1160
[7]   Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival [J].
Denhardt, DT ;
Noda, M ;
O'Regan, AW ;
Pavlin, D ;
Berman, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1055-1061
[8]   T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3 [J].
Hwang, ES ;
Szabo, SJ ;
Schwartzberg, PL ;
Glimcher, LH .
SCIENCE, 2005, 307 (5708) :430-433
[9]   Cutting edge: Attenuated experimental autoimmune encephalomyelitis in Eta-1/osteopontin-deficient mice [J].
Jansson, M ;
Panoutsakopoulou, V ;
Baker, J ;
Klein, L ;
Cantor, H .
JOURNAL OF IMMUNOLOGY, 2002, 168 (05) :2096-2099
[10]   Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells [J].
Koguchi, Y ;
Kawakami, K ;
Kon, S ;
Segawa, T ;
Maeda, M ;
Uede, T ;
Saito, A .
INFECTION AND IMMUNITY, 2002, 70 (03) :1042-1048